Karen Marie Walker serves as Executive at Kyverna Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Karen Marie Walker has executed 3 insider transactions totaling $292.8K, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 15, 2025 involved selling 23,998 shares valued at $292.8K.
Karen Marie Walker currently holds 22,636 shares of Kyverna Therapeutics, Inc. (KYTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Karen Marie Walker has been a net seller of KYTX stock. They have purchased $0 and sold $292.8K worth of shares.
Karen Marie Walker's most recent insider trade was on Dec 15, 2025, when they sold 23,998 shares at $12.20 per share.
Get notified when new Form 4 filings are submitted
| $4.83 |
| Discretionary |
| Jun 6, 2024 | KYTX | $42.6K | Option Exercise | 9,636 | $4.42 | Discretionary |